Background: The pathogenesis of asthma is believed to reflect antigen-induced airway inflammation leading to the recruitment of eosinophils and activation of mast cells through cell-associated IgE. Controversies persist however, regarding the relative importance of different pathogenic cells and effector molecules. Materials and Methods: A variety of gene-targeted mice were examined for the induction of cholinergic airway hyperresponsiveness (AH), allergic airway inflammation, mucus production, and serum IgE reactivity following intratracheal challenge with a potent allergen. AH was determined using whole-body plethysmography following acetylcholine challenge. Where possible, results were confirmed using neutralizing antibodies and cell-specific reconstitution of immune deficient mice.
Introduction
Asthma is a complex clinical disorder marked by reversible episodes of airway narrowing and in-the production of IgE antibodies (by IL-4 and IL-13) that ultimately cause pathologic changes, including damage and sloughing of the respiratory epithelium, excess mucus production, airway edema, and changes in airway smooth muscle that collectively lower the threshold for airway narrowing to a variety of stimuli, termed airway hyperresponsiveness (AH) (6, 7) .
Recently, mouse models of allergic airway inflammation have been used to identify host determinants involved in the inflammatory and physiologic changes associated with human asthma. As expected, T cell-deficient mice failed to develop lung inflammation and AH (8) (9) (10) (11) , and the role for Th2 cells predicted by the human studies was validated using anti-IL-4 and anti-IL-4 receptor antibodies and in IL-4-deficient mice, which failed to develop antigen-induced airway changes in most (8, 12, 13) , but not all (14) , studies. Activity mediated in the absence of IL-4 may reflect the capacity of IL-13, which can be coordinately expressed with IL-4 in asthma (15) , to itself direct Th2 differentiation through STAT6-mediated stimulation in some strains of mice (16) . Mice engineered to express excessive amounts of IL-4 in the lung developed tissue inflammation, including eosinophils, and baseline elevations of pulmonary resistance, but they did not develop AH, indicating additional requirements for the full spectrum of disease (17) . Roles for eosinophils, IL-5 and IgE in AH have been more variable, with some studies suggesting a necessary role and others demonstrating one or all to be dispensable (reviewed in refs. 18, 19 , and discussed below).
The fungus Aspergillus fumigatus has been shown to be a potent pulmonary allergen (20) and is known to cause allergic airways disease in humans (21) . We used an extract of Aspergillus that induced AH across a range of inbred mouse strains to investigate the critical components of the host response required to generate AH in the mouse. AH was rigorously quantitated in the intact animal while breathing at physiologic tidal volumes. As assessed in both CD4+ T cell-reconstituted, recombinase-activating-gene (RAG)-deficient mice and in B cell-deficient mice, T cells were sufficient to mediate acute AH and lung infiltration by inflammatory cells. Furthermore, depletion of eosinophils to baseline levels had no effect on the physiologic or immunologic changes mediated by CD4+ T cells. IL-4, but not IL-5, emerged as a critical effector molecule mediating AH. This model should be useful in elucidating the minimal signals required to elicit allergen-induced lung disease.
Materials and Methods
Mice Female C57BL/6 (Jackson Laboratories, Bar Harbor, ME) and 129Sv/Ev (Taconic Laboratories, Germantown, NY) mice were used at 6-10 weeks of age. Mice rendered deficient in B cells by targeted disruption of the membrane exon of the immunoglobulin ,u chain gene (22) and mice rendered deficient in T and B cells by disruption of the recombinase activating gene-I (RAG-1) (23) were purchased from Jackson Laboratories and backcrossed six times to C57BL/6 mice. RAG-2-deficient mice (24) were on the 129SvEv background (Taconic Laboratories), IL-4-deficient mice (25) were on the 129Sv/Ev background, and IL-5-deficient (26) mice were on the C57BL/6 background.
Antigen sensitization
Aspergillus fumigatus antigens represent a mixture of culture filtrate and mycelial extract prepared free of living organisms (27) . Batches #5323R1 and 5325 with equivalent activities were aliquoted at 10 mg/ml and stored at -70°C prior to use. The endotoxin content of the extract was less than 0.1 EU/100 jig antigen.
For sensitization, anesthetized mice were given 100 gg Aspergillus extract in 50 gl phosphate-buffered saline (PBS) intranasally five times at 4-day intervals as described previously (20) The numbers of IL-4-producing cells were quantitated using enzyme-linked immunocell spot (ELISPOT) assays as described previously (8) . Briefly, duplicate cell samples were distributed to 96-well microtiter plates that had been precoated with mAb 1 BIl1 anti-murine-IL-4 antibody, serial 2-fold dilutions of the cells were carried out, and the plates were incubated undisturbed for 18 hr at 370C. After washing away the cells, biotinylated secondary antibody against IL-4, BVD6-24G.2, was added. Captured IL-4 was revealed using streptavidin-conjugated alkaline phosphatase and developed using 5-bromo-4-chloro-indolyl-phosphate in 0.1 M 2-amino-2-methyl-i -propanol buffer suspended in 0.6% agarose. Individual blue spots were counted after solidification of the agar using inverted microscopy.
Serum was prepared from whole blood collected at the time of death for determination of total IgE and IgG levels using sandwich monoclonal antibody-based ELISA as described elsewhere (8) .
Tissue pathology For histologic analysis, whole lungs were infused via the trachea with 4% formalin until distended and fixed for 24 hr. The tissues were embedded in paraffin, and 2-to 3-,um sections were cut and stained with hematoxylin and eosin or periodic acid-Schiff for viewing by light microscopy.
T cell reconstitutions
Spleen, inguinal, and axillary lymph nodes were harvested from C57BL/6 or 129SvEv mice. The tissues were finely minced and dispersed into single-cell suspensions by passage through a 0.75-,um nylon mesh filter. Cells were washed twice, counted, and depleted of B cells, MHC class II-and CD8-bearing cells using monoclonal antibodies Jlld, BP107, and 3.155 (all from American Type Culture Collection; Rockville, MD), respectively, and low-toxicity rabbit and guinea pig complement (Cedarlane; Ontario, Canada). The resulting cells were labeled with phycoerythrin (PE)-conjugated anti-B220, FITCconjugated anti-Thy (Fig. 1) . RAG-deficient mice also failed to develop the degree of airway inflammation-airway eosinophils and increases in the numbers of IL-4-producing cells in the lung-that characterized the response in wildtype mice, although some increases in BAL eosinophils could be consistently shown ( Table 1) . The inflammatory changes were markedly suppressed compared with those in wild-type mice, however, as revealed in multiple histologic sections from lungs, and this did not differ between RAG--I-and RAG-2 --mice (Fig. 2) . Thus, lymphocytes were required to mediate both the physiologic and pathologic changes that occured in the airways of mice challenged with the fungal antigens.
RAG-deficient mice reconstituted with CD4+ T cells manifest allergen-induced physiologic and pathologic findings in the lungs To confirm that T cells alone, and particularly CD4+ T cells, could mediate the pathologic changes associated with asthma, spleen and lymph node CD4+ T cells from the appropriate matched donor animals were purified by flow cytometry and were passively transferred into RAG-1-or RAG-2-deficient mice. The reconstituted mice were sensitized with antigen or saline, and the pathologic and physiologic changes were assessed. In contrast to nonreconstituted RAG-deficient mice, mice reconstituted with CD4+ T cells developed AH to acetylcholine (Fig. 1 (30, 42, 43) . In contrast, other investigators have reported a critical role for IgE in eosinophil recruitment as studied using anti-IgE antibodies (44) or in analysis of hyper-IgE-producing lines of mice (45) , or in inducing tracheal smooth muscle hyperresponsiveness (31, 46, 47) . Similarly, studies in mice rendered eosinophil deficient by targeted disruption of the IL-5 gene (48) or in mice administered anti-IL-5 antibodies (14,45) demonstrated a role for IL-5-dependent eosinophilia in mediating airway hyperreactivity, whereas other studies using neutralizing antibodies could demonstrate no role for IL-5 or elevated tissue eosinophil numbers (8, 49) . These investigations have used different techniques for quantitating airway physiology, and they have used a variety of antigens for sensitization, some of which display genetic differences among various inbred strains of mice (18) . It The demonstration that CD4+ T cells could mediate acute allergen-induced airways disease raises questions regarding the mechanism(s) involved. The mechanism is ultimately quite different than that mediated by immune complexes or antigen in Arthus-like reactions. Pulmonary inflammation was markedly reduced in mice deficient in either the substance P receptor, NK-1R, or the C5a anaphylatoxin receptor when challenged with antigen-antibody complexes (50) , and cutaneous and systemic Arthus reactions were completely abrogated in mice with disruption of high-and low-affinity Fc receptors (51) . The absence of immunoglobulin in the B celldeficient mice or T cell-reconstituted RAG-deficient mice precluded activation of these types of inflammatory cascades. Potential interactions between Th2 cells and resident pulmonary cells that might serve as sources of distinct inflammatory pathways mediated by chemokines (1 1, 52-56), interleukins (57) , or the induction of homing and adhesion molecules (11, 58) merit further study. Studies in B cell-deficient and RAG-reconstituted mice should be informative in defining the necessary and sufficient roles for such effector molecules. Although the requirement for suggests that Th2 cells were required and sufficient to mediate disease, further studies will be needed to establish whether production is necessary only from CD4+ T (59, 60) . Furthermore, an inverse relationship was noted between the predilection for asthma and the degree of CD4+ T cell depletion among patients infected with HIV, despite the common association of elevated IgE levels with progressive disease (61) . Thus, the association of elevated IgE and eosinophil levels with asthma may not indicate a causal role in the pathogenesis. In murine intestinal helminth infections, systems in which protective immunity is mediated by Th2 cells, no requisite role has been demonstrated for either IgE or eosinophils in immunity, despite their marked elevations in vivo (26, 62) .
The prevalence of asthma has risen steadily, such that 6-14% of children in the United States and Great Britain are affected (63,64). As noted above, a number of the pathologic and physiologic aspects of asthma are similar to those induced in this murine model. Human asthma is thought to be induced by a number of relatively common environmental antigens. Genetic studies in human populations have suggested linkage to areas near the cytokine locus that encodes IL-4, IL-5, IL-13, IL-9, and GM-CSF on chromosome 5q (65, 66) , raising the possibility that aberrant type-2 responses may occur in the lung because of genetic factors that concordantly link these cytokine responses. The inverse relationship demonstrated in population studies between the intensity of delayed type hypersensitivity, a type 1-mediated response, and the incidence of atopy and asthma, provides additional support for this hypothesis (67) . The data reported here suggest that early interventions that target the activation and/or effector development of T cells specific for candidate environmental allergens might abrogate the subsequent development of lung disease by preventing the chronic recruitment of additional cells and mediators that amplify the tissue-destructive process. The model described should be useful for revealing the minimal interactions between CD4+ T cells and endogenous cells of the lung that mediate airway pathology. 
